This is an extensive consultation process that includes WADAs List Expert Advisory Group gathering information including the latest scientific and medical research, trends, and intelligence gathered from law enforcement and pharmaceutical companies
The "as needed" approach reflects that NAD+ is a coenzyme, not a receptor agonist there's no desensitization concern in the same way
Related articles Related Qustion BPC 157: Uses, Dosages, Benefits and Side Effects Dec 16, 2024 Body Protection Compound 157 (BPC 157) is a peptide consisting of 15 amino acids
If you take 2000 mcg or more of adenosylcobalamin with hydroxocobalamin, you may get too much vitamin B12
FDA approval costs hundreds of millions to over a billion dollars, a bet pharma only makes when there's a patent to protect
All of our content is reviewed by medical doctors and doctoral-level experts in pharmacology, toxicology, and chemistry